BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 20353134)

  • 1. Changes in the humoral immune responses after chemotherapy in single and co-infected individuals with Schisosoma haematobium and Plasmodium falciparum.
    Zinyowera S; Muchaneta-Kubara CE; Mutapi F; Midzi N; Ndlovu PD; Mduluza T
    Cent Afr J Med; 2006; 52(9-12):104-11. PubMed ID: 20353134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
    Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
    Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schistosomiasis co-infection in humans influences inflammatory markers in uncomplicated Plasmodium falciparum malaria.
    Diallo TO; Remoue F; Schacht AM; Charrier N; Dompnier JP; Pillet S; Garraud O; N'diaye AA; Capron A; Capron M; Riveau G
    Parasite Immunol; 2004; 26(8-9):365-9. PubMed ID: 15679634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-malaria humoral responses in children exposed to Plasmodium falciparum and Schistosoma haematobium.
    Mutapi F; Roussilhon C; Mduluza T; Druilhe P
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(3):405-9. PubMed ID: 17568947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG responses associated with protection against malaria.
    Courtin D; Djilali-Saïah A; Milet J; Soulard V; Gaye O; Migot-Nabias F; Sauerwein R; Garcia A; Luty AJ
    Parasite Immunol; 2011 Feb; 33(2):124-31. PubMed ID: 21226725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exposure, infection, systemic cytokine levels and antibody responses in young children concurrently exposed to schistosomiasis and malaria.
    Imai N; Rujeni N; Nausch N; Bourke CD; Appleby LJ; Cowan G; Gwisai R; Midzi N; Cavanagh D; Mduluza T; Taylor D; Mutapi F
    Parasitology; 2011 Oct; 138(12):1519-33. PubMed ID: 21813042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
    Khalil HM; Abd el Baki MH; Abd el Mawla MM; Maklad KM; Sharaf SA; Saad AE
    J Egypt Soc Parasitol; 1999 Aug; 29(2):395-408. PubMed ID: 10605492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe.
    Ndhlovu P; Cadman H; Vennervald BJ; Christensen NO; Chidimu M; Chandiwana SK
    Parasite Immunol; 1996 Apr; 18(4):181-91. PubMed ID: 9223173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific B memory cell responses to Plasmodium falciparum malaria antigens and Schistosoma haematobium antigens in co-infected Malian children.
    Lyke KE; Wang A; Dabo A; Arama C; Daou M; Diarra I; Plowe CV; Doumbo OK; Sztein MB
    PLoS One; 2012; 7(6):e37868. PubMed ID: 22693628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on immune status of patients with schistosomiasis japonica in Poyang Lake region I characterization of antigen-specific antibody isotype responses to Schistosoma japonicum].
    Xie SY; Yuan M; Hu F; Liu YM; Zeng XJ; Tao B; Li YF; Liu JP; Wang JM; Gao ZL; Li JY; Chen HG; Lin DD
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2012 Oct; 24(5):510-3, 521. PubMed ID: 23373252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Schistosoma IgG responses in Schistosoma haematobium single and concomitant infection with malaria parasites.
    Morenikeji OA; Adeleye O; Omoruyi EC; Oyeyemi OT
    Pathog Glob Health; 2016 Mar; 110(2):74-8. PubMed ID: 27092873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-Stratified Profiles of Serum IL-6, IL-10, and TNF-α Cytokines Among Kenyan Children with Schistosoma haematobium, Plasmodium falciparum, and Other Chronic Parasitic Co-Infections.
    Bustinduy AL; Sutherland LJ; Chang-Cojulun A; Malhotra I; DuVall AS; Fairley JK; Mungai PL; Muchiri EM; Mutuku FM; Kitron U; King CH
    Am J Trop Med Hyg; 2015 May; 92(5):945-51. PubMed ID: 25758654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary soluble egg antigen levels in Schistosoma haematobium infection in relation to sex and age of Kenyan schoolchildren following praziquantel treatment.
    Kihara JH; Njagi EN; Kenya EU; Mwanje MT; Odek AE; van Dam G; Kahama AI; Ouma JH
    Trans R Soc Trop Med Hyg; 2009 Oct; 103(10):1024-30. PubMed ID: 19647844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of humoral immune response to Plasmodium falciparum blood stages in individuals presenting different clinical expressions of malaria.
    Leoratti FM; Durlacher RR; Lacerda MV; Alecrim MG; Ferreira AW; Sanchez MC; Moraes SL
    Malar J; 2008 Sep; 7():186. PubMed ID: 18816374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity after treatment of human schistosomiasis: association between IgE antibodies to adult worm antigens and resistance to reinfection.
    Dunne DW; Butterworth AE; Fulford AJ; Kariuki HC; Langley JG; Ouma JH; Capron A; Pierce RJ; Sturrock RF
    Eur J Immunol; 1992 Jun; 22(6):1483-94. PubMed ID: 1601036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schistosoma haematobium effects on Plasmodium falciparum infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon.
    Dejon-Agobé JC; Zinsou JF; Honkpehedji YJ; Ateba-Ngoa U; Edoa JR; Adegbite BR; Mombo-Ngoma G; Agnandji ST; Ramharter M; Kremsner PG; Lell B; Grobusch MP; Adegnika AA
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006663. PubMed ID: 30080853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of treating Schistosoma haematobium infection on Plasmodium falciparum-specific antibody responses.
    Reilly L; Magkrioti C; Mduluza T; Cavanagh DR; Mutapi F
    BMC Infect Dis; 2008 Nov; 8():158. PubMed ID: 19014683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schistosoma haematobium infection modulates Plasmodium falciparum parasite density and antimalarial antibody responses.
    Tokplonou L; Nouatin O; Sonon P; M'po G; Glitho S; Agniwo P; Gonzalez-Ortiz D; Tchégninougbo T; Ayitchédji A; Favier B; Donadi EA; Milet J; Luty AJF; Massougbodji A; Garcia A; Ibikounlé M; Courtin D
    Parasite Immunol; 2020 Apr; 42(4):e12702. PubMed ID: 32020650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between specific antibody responses and resistance to reinfection in a Senegalese population recently exposed to Schistosoma mansoni.
    Vereecken K; Naus CW; Polman K; Scott JT; Diop M; Gryseels B; Kestens L
    Trop Med Int Health; 2007 Mar; 12(3):431-44. PubMed ID: 17313515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine and chemokine profile of the innate and adaptive immune response of Schistosoma haematobium and Plasmodium falciparum single and co-infected school-aged children from an endemic area of Lambaréné, Gabon.
    Ateba-Ngoa U; Adegnika AA; Zinsou JF; Kassa Kassa RF; Smits H; Massinga-Loembe M; Mordmüller B; Kremsner PG; Yazdanbakhsh M
    Malar J; 2015 Feb; 14():94. PubMed ID: 25890010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.